Macromoltek
Computational antibody design
Macromoltek is active in the healthcare space based in Austin, TX, USA.
Profile
Macromoltek: Revolutionizing antibody design.
Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Macromoltek is positioned in healthcare, a segment that rewards a clear, focused offering.
The company is recorded as being based in Austin, TX, USA.
Its current recorded stage is Winter 2018.
Recorded headcount: 14 employees.
Total disclosed funding stands at about $1.2M.
| Sector | Healthcare |
|---|---|
| Headquarters | Austin, TX, USA |
| Country | United States |
| Employees | 14 |
| Stage | Winter 2018 |
| Total funding | $1,193,494 |
Website: www.macromoltek.com
Browse related
Create a free account